Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus Cream 1% in Mild to Moderate Atopic Dermatitis
NCT00150059Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pimecrolimus in atopic dermatitis (AD), sponsored by Novartis. Primary endpoints: Investigator Global Assessment, Pruritus Severity Assessment at Day 90 and 2 more. Started Dec 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00150059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150059.